当代健康公平框架在妇科癌症诊疗中的应用:妇科肿瘤学会循证综述
本文是妇科肿瘤学会的循证综述,将健康差异框架更新为纳入健康社会决定因素,以解决医疗系统内差异的根源。文章识别了黑人种族、服务不足的少数族裔、跨性别/性别非常规人群及农村人群等健康不公平风险人群,并为其独特的结构性障碍提供实践建议。
要点
- 健康差异是社会弱势人群相较总体人群可预防的疾病、伤害、暴力负担或获得最佳健康机会的差异。
- 妇科恶性肿瘤的发病率和癌症结局差异已被充分描述,尤其针对美国黑人女性。
- 作者为从业者提供旨在消除癌症相关结局差异的实践建议。
核心结论
- 文章更新了差异框架,纳入对健康社会决定因素的更广泛理解,通过解决医疗系统内差异的根源来影响健康公平。
研究设计与样本
- 本文为妇科肿瘤学会的循证综述。
主要发现
- 宫颈癌和卵巢癌的生存主要与获得高质量治疗相关,而子宫体癌的发病率和死亡率差异主要归因于先天生物学差异。
- 健康不公平风险人群包括但不限于黑人种族、服务不足的种族和族裔少数群体(如原住民、英语流利度低者)、跨性别/性别非常规人群和农村人群。
- 每个风险人群在医疗系统内均有独特的结构性障碍,影响妇科癌症结局。
临床怎么用
- 作者为从业者提供旨在消除癌症相关结局差异的实践建议。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Health disparities are defined as the preventable difference in the burden of disease, injury, and violence, or opportunity to achieve optimal health that socially disadvantaged populations experience compared to the population as a whole. Disparities in incidence and cancer outcomes for women with gynecologic malignancies have been well described particularly for American women of Black race. The etiology of these disparities has been tied to socio-economics, cultural, educational and genetic factors. While access to high quality treatment has been primarily linked to survival from cervical and ovarian cancer, innate biologic distinctions have been principally cited as reasons for differences in incidence and mortality in cancers of the uterine corpus. This article will update the framework of disparities to incorporate a broader understanding of the social determinants of health and how they affect health equity by addressing the root causes of disparities within the health care system. Special populations are identified who are at risk for health inequities which include but are not limited to Black race, underserved racial and ethnic minorities (e.g. indigenous peoples, low English fluency), trans/gender nonconforming people and rural populations. Each of these populations at risk have unique structural barriers within the healthcare system impacting gynecologic cancer outcomes. The authors provide practical recommendations for practitioners aimed at eliminating cancer related outcome disparities.
引用
- Temkin SM, Rimel BJ, Bruegl AS, et al. A contemporary framework of health equity applied to gynecologic cancer care: A Society of Gynecologic Oncology evidenced-based review. Gynecol Oncol. 2018. PMID: 29605053. doi:10.1016/j.ygyno.2017.11.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。